Viropil (PeP)

What is Viropil?

Viropil is an antiretroviral medication used primarily for the prevention of HIV infection. It is part of a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs), which work by preventing the virus from replicating within the body. Viropil is often prescribed in the context of Post-Exposure Prophylaxis (PEP), a critical intervention for individuals who may have been exposed to HIV through high-risk activities.

What is Viropil Used For?

Viropil serves a vital role in PEP, which is a short-term treatment initiated after potential exposure to HIV. The main objectives of Viropil in this context include: HIV Prevention: The primary use of Viropil is to reduce the risk of HIV infection following possible exposure. When taken as part of a PEP regimen, it significantly decreases the likelihood of the virus establishing a permanent infection.

Emergency Situations: Viropil is often prescribed in emergency situations, such as after unprotected sex, sexual assault, or occupational exposure (e.g., needle-stick injuries in healthcare settings). It is crucial for individuals who believe they may have been exposed to HIV to seek medical attention immediately.

Duration of Treatment: For optimal effectiveness, Viropil should be started within 72 hours after potential exposure and is usually taken for a total of 28 days. Adherence to the full course of treatment is essential for maximizing protection against HIV.

Viropil is an important medication in the fight against HIV, particularly in emergency situations where exposure may have occurred. As a key component of Post-Exposure Prophylaxis (PEP), it helps individuals reduce their risk of infection. If you suspect you have been exposed to HIV, it is crucial to consult a healthcare professional promptly to discuss PEP options and determine the best course of action for your health.

Post-exposure prophylaxis (PeP) is a medical treatment used after a potential exposure to HIV to prevent infection. This treatment should be started as soon as possible, ideally within 24 hours after exposure and no later than 72 hours. The medications used in PeP include a combination of three antiretroviral drugs. Viropil contains Tenofovir disoproxil fumarate, Lamivudine, and Dolutegravir (Tivicay). This medication is administered orally for the 28 days following exposure.